Aptus Pharma Ltd
Aptus Pharma Ltd - 544529 - Board Meeting Intimation for Consideration Of Unaudited Financial Results For The Half Year Ended On September 30, 2026 And Closure Of Trading Window
Filing Details / Description
Aptus Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/10/2026 ,inter alia, to consider and approve Board Meeting Intimation for consideration ....